Imago BioSciences, Inc. Operating Income
Imago BioSciences, Inc. reported Operating Income of -$17.55 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2022-11-09
- Imago BioSciences, Inc. operating income (loss) for the quarter ending 2022-09-30 was -$17.55M.
- Imago BioSciences, Inc. operating income (loss) for the quarter ending 2022-06-30 was -$14.02M.
- Imago BioSciences, Inc. operating income (loss) for the quarter ending 2022-03-31 was -$16.51M.
- Imago BioSciences, Inc. operating income (loss) for the quarter ending 2021-12-31 was -$14.81M.
- Imago BioSciences, Inc. operating income (loss) for fiscal 2021 was -$42.52M.
- Imago BioSciences, Inc. operating income (loss) for fiscal 2020 was -$18.07M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$17.55M 10-Q · filed 2022-11-09 | -$31.56M derived: sum of 2 quarters · filed 2022-11-09 | -$48.08M 10-Q · filed 2022-11-09 | -$62.89M derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | -$14.02M 10-Q · filed 2022-08-12 | -$30.53M 10-Q · filed 2022-08-12 | -$45.34M derived: sum of 3 quarters · filed 2022-08-12 | -$57.06M derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-03-31 | -$16.51M 10-Q · filed 2022-05-12 | -$31.33M derived: sum of 2 quarters · filed 2022-05-12 | -$43.05M derived: sum of 3 quarters · filed 2022-11-09 | -$51.89M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-12-31 | -$14.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$26.53M derived: sum of 2 quarters · filed 2022-11-09 | -$35.38M derived: sum of 3 quarters · filed 2022-11-09 | -$42.52M 10-K · filed 2022-03-24 |
| 2021-09-30 | -$11.72M 10-Q · filed 2022-11-09 | -$20.56M derived: sum of 2 quarters · filed 2022-11-09 | -$27.71M 10-Q · filed 2022-11-09 | -$33.28M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$8.84M 10-Q · filed 2022-08-12 | -$15.99M 10-Q · filed 2022-08-12 | -$21.56M derived: sum of 3 quarters · filed 2022-08-12 | -$25.87M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | -$7.15M 10-Q · filed 2022-05-12 | -$12.71M derived: sum of 2 quarters · filed 2022-05-12 | -$17.02M derived: sum of 3 quarters · filed 2022-05-12 | -$21.03M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$5.57M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$9.88M derived: sum of 2 quarters · filed 2022-03-24 | -$13.88M derived: sum of 3 quarters · filed 2022-03-24 | -$18.07M 10-K · filed 2022-03-24 |
| 2020-09-30 | -$4.31M 10-Q · filed 2021-11-10 | -$8.31M derived: sum of 2 quarters · filed 2021-11-10 | -$12.51M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$4.00M 10-Q · filed 2021-08-19 | -$8.20M 10-Q · filed 2021-08-19 |